| scholarly article | Q13442814 |
| P50 | author | Nora Volkow | Q457967 |
| P2093 | author name string | Panayotis K Thanos | |
| Basalingappa L Hungund | |||
| K Yaragudri Vinod | |||
| Thomas B Cooper | |||
| Csaba Vadasz | |||
| Ratnakumar Yalamanchili | |||
| P2860 | cites work | Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence | Q28200994 |
| Identification and functional characterization of brainstem cannabinoid CB2 receptors | Q28276972 | ||
| Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice | Q28343324 | ||
| Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction | Q28363073 | ||
| Cannabinoid receptor signaling. | Q30353713 | ||
| Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain | Q31570267 | ||
| Behavioral effects of cannabinoid agents in animals | Q33914022 | ||
| Using markers in gene introgression breeding programs | Q33960239 | ||
| Towards a molecular epidemiology of alcohol dependence: analysing the interplay of genetic and environmental risk factors | Q34226866 | ||
| Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice | Q34331157 | ||
| Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats | Q34374106 | ||
| Modulation of transmitter release via presynaptic cannabinoid receptors | Q34430714 | ||
| Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand | Q34522513 | ||
| Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. | Q34605939 | ||
| Alcohol and withdrawal: from animal research to clinical issues | Q35146112 | ||
| Anandamide as an intracellular messenger regulating ion channel activity | Q36228963 | ||
| Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders | Q36425951 | ||
| Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain | Q36653994 | ||
| The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence | Q36977773 | ||
| Differences in basal levels of CREB and NPY in nucleus accumbens regions between C57BL/6 and DBA/2 mice differing in inborn alcohol drinking behavior | Q42453594 | ||
| Cannabinoid receptor agonist-stimulated [35S]guanosine triphosphate gammaS binding in the brain of C57BL/6 and DBA/2 mice. | Q43599706 | ||
| Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration | Q43754879 | ||
| Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels | Q43890403 | ||
| Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats | Q43893862 | ||
| Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity. | Q44046073 | ||
| Effect of CGP39551 administration on the kindling of ethanol-withdrawal seizures | Q44119367 | ||
| Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine | Q44189376 | ||
| Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens | Q44299680 | ||
| A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. | Q44376616 | ||
| Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. | Q44561648 | ||
| Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. | Q44697078 | ||
| Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain | Q44785227 | ||
| Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice | Q44923318 | ||
| Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors | Q44926114 | ||
| Anxiety-like behavior in mice in two apparatuses during withdrawal from chronic ethanol vapor inhalation | Q44977094 | ||
| Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors | Q46685295 | ||
| The decreased cyclic-AMP dependent-protein kinase A function in the nucleus accumbens: a role in alcohol drinking but not in anxiety-like behaviors in rats | Q46727182 | ||
| Pharmacological manipulation of CB1 receptor function alters development of tolerance to alcohol | Q46745727 | ||
| Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice | Q47994629 | ||
| The lack of CB1 receptors prevents neuroadapatations of both NMDA and GABA(A) receptors after chronic ethanol exposure. | Q48198712 | ||
| Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans | Q48327338 | ||
| Central and medial amygdaloid brain-derived neurotrophic factor signaling plays a critical role in alcohol-drinking and anxiety-like behaviors. | Q48450802 | ||
| Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra | Q48461656 | ||
| Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system | Q48478439 | ||
| Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats | Q48485540 | ||
| Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors | Q48518726 | ||
| CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia | Q48599063 | ||
| Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. | Q49158559 | ||
| Low endogenous dopamine function in brain predisposes to high alcohol preference and consumption: reversal by increasing synaptic dopamine | Q72151447 | ||
| Scanning of five chromosomes for alcohol consumption loci | Q73276461 | ||
| Cannabinoid-serotonin interactions in alcohol-preferring vs. alcohol-avoiding mice | Q80302976 | ||
| P433 | issue | 8 | |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 574-581 | |
| P577 | publication date | 2008-08-01 | |
| P1433 | published in | Synapse | Q7662025 |
| P1476 | title | Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice | |
| P478 | volume | 62 |
| Q34264449 | A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research. |
| Q37597181 | A spontaneous deletion of α-synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: effects on alcohol consumption. |
| Q40168348 | Acute and chronic ethanol exposure differentially regulate CB1 receptor function at glutamatergic synapses in the rat basolateral amygdala |
| Q47225379 | Acute and chronic modulation of striatal endocannabinoid-mediated plasticity by nicotine |
| Q50125207 | Acute ethanol inhibition of adult hippocampal neurogenesis involves CB1 cannabinoid receptor signaling. |
| Q37387731 | Agonism of the endocannabinoid system modulates binge-like alcohol intake in male C57BL/6J mice: involvement of the posterior ventral tegmental area |
| Q57299911 | Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice |
| Q37444808 | Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders |
| Q36431393 | Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug? |
| Q47647272 | Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling |
| Q43202780 | Converging action of alcohol consumption and cannabinoid receptor activation on adult hippocampal neurogenesis |
| Q35589974 | Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawal |
| Q30569742 | Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse |
| Q34301263 | Effects of the novel cannabinoid CB1 receptor antagonist PF 514273 on the acquisition and expression of ethanol conditioned place preference. |
| Q92097847 | Endocannabinoid System and Alcohol Abuse Disorders |
| Q93024468 | Ethanol-induced alterations in endocannabinoids and relevant neurotransmitters in the nucleus accumbens of fatty acid amide hydrolase knockout mice |
| Q37635751 | Genes and Alcohol Consumption: Studies with Mutant Mice |
| Q27315226 | Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors |
| Q35103644 | Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats |
| Q36405131 | Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons |
| Q41911434 | Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine |
| Q48374981 | Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison |
| Q58102489 | Medical Use of Cannabinoids |
| Q47942161 | Medications for alcohol use disorders: An overview |
| Q94417350 | Pharmacological Inhibition of Brain Fatty Acid Binding Protein Reduces Ethanol Consumption in Mice |
| Q28241318 | Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategies |
| Q36162168 | Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependence |
| Q37386356 | Resilience to meet the challenge of addiction: psychobiology and clinical considerations |
| Q39384586 | Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol. |
| Q36373102 | Roles for the endocannabinoid system in ethanol-motivated behavior. |
| Q33886361 | Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides |
| Q34419703 | Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption. |
Search more.